Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope.
about
Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradomeRecent progress in tumour vaccine development.Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cellsReverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.
P2860
Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Amino acid modifications in th ...... y of this self tumour epitope.
@en
Amino acid modifications in th ...... y of this self tumour epitope.
@nl
type
label
Amino acid modifications in th ...... y of this self tumour epitope.
@en
Amino acid modifications in th ...... y of this self tumour epitope.
@nl
prefLabel
Amino acid modifications in th ...... y of this self tumour epitope.
@en
Amino acid modifications in th ...... y of this self tumour epitope.
@nl
P2093
P2860
P356
P1476
Amino acid modifications in th ...... y of this self tumour epitope.
@en
P2093
Jean-Gérard Guiller
Jean-Paul Briand
Michèle Kayibanda
Mireille Viguier
Myriam Baratin
Raphäelle Romieu
P2860
P304
P356
10.1002/PSC.391
P577
2002-07-01T00:00:00Z